| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,294 | 5,259 | 5,270 | 5,118 | | Cost of Revenue | 708 | 468 | 654 | 439 | | | Gross Profit | 5,586 | 4,791 | 4,616 | 4,679 | | | Operating Expenses | | Research Development | 3,256 | 3,425 | 3,006 | 4,244 | | Selling General and Administrative | 1,758 | 3,283 | 2,321 | 2,410 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 572 | (1,917) | (711) | (1,975) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3 | 4 | 7 | 35 | | Earnings Before Interest And Taxes | 575 | (1,913) | (704) | (1,940) | | Interest Expense | 192 | 225 | 258 | 292 | | Income Before Tax | 383 | (2,138) | (962) | (2,232) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 383 | (2,138) | (962) | (2,232) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 383 | (2,138) | (962) | (2,232) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $383 | ($2,138) | ($962) | ($2,232) |
|
0.01% Nasdaq 
Income Statement
